Literature DB >> 15864376

The 2004 WHO classification of bladder tumors: a summary and commentary.

Rodolfo Montironi1, Antonio Lopez-Beltran.   

Abstract

The key points of the latest World Health Organization (WHO) classification of non-invasive urothelial tumors are the following: the description of the categories has been expanded to improve their recognition; a tumor with particularly good prognosis (papillary urothelial neoplasm of low malignant potential) no longer carries the label of 'cancer'; it avoids the use of ambiguous grading such as grade 1/2 or 2/3 (as done in the 1973 WHO classification); the group of noninvasive high-grade carcinoma is large enough to virtually contain all those tumors having biological properties similar to those seen in invasive urothelial carcinoma, and a similarly high level of genetic instability. This scheme is meant to replace the 1973 WHO classification, but the use of both the 1973 and the latest WHO classifications is recommended until the latter is sufficiently validated.

Entities:  

Mesh:

Year:  2005        PMID: 15864376     DOI: 10.1177/106689690501300203

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  70 in total

Review 1.  Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC).

Authors:  Courtney Pollard; Steven C Smith; Dan Theodorescu
Journal:  Expert Rev Mol Med       Date:  2010-03-25       Impact factor: 5.600

2.  HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Marco Moschini; Andrea Haitel; Gregory J Wirth; Jose A Karam; Christopher G Wood; Morgan Rouprêt; Vitaly Margulis; Pierre I Karakiewicz; Alberto Briganti; Jay D Raman; Solene-Florence Kammerer-Jacquet; Romain Mathieu; Karim Bensalah; Yair Lotan; Mehmet Özsoy; Mesut Remzi; Kilian M Gust; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-06-07       Impact factor: 4.226

3.  Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.

Authors:  Philip H Kim; Ranjit Sukhu; Billy H Cordon; John P Sfakianos; Daniel D Sjoberg; A Ari Hakimi; Guido Dalbagni; Oscar Lin; Harry W Herr
Journal:  BJU Int       Date:  2014-02-14       Impact factor: 5.588

4.  The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.

Authors:  Stefania Zamboni; Marco Moschini; Andrea Gallina; Renzo Colombo; Francesco Montorsi; Alberto Briganti; Andrea Salonia; Alessandro Antonelli; Claudio Simeone; Sandra Belotti; Luca Cristinelli; Agostino Mattei; Philipp Baumeister
Journal:  World J Urol       Date:  2019-03-25       Impact factor: 4.226

5.  Robotic assisted laparoscopic radical cystectomy with stentless intracorporeal modified Ves.Pa neobladder: early experience.

Authors:  Patrick Whelan; Wei Phin Tan; Dimitri Papagiannopoulos; Philip Omotosho; Leslie Deane
Journal:  J Robot Surg       Date:  2017-01-09

6.  Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.

Authors:  Virginia Urquidi; Steve Goodison; Jeongsoon Kim; Myron Chang; Yunfeng Dai; Charles J Rosser
Journal:  Urology       Date:  2012-03-03       Impact factor: 2.649

7.  High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Authors:  Doreen Nguyen; Diana Taheri; Simeon Springer; Morgan Cowan; Gunes Guner; Maria Angelica Mendoza Rodriguez; Yuxuan Wang; Isaac Kinde; Christopher J VandenBussche; Matthew T Olson; Bernardo F P Ricardo; Isabela Cunha; Kazutoshi Fujita; Dilek Ertoy; Kenneth W Kinzler; Trinity J Bivalacqua; Nickolas Papadopoulos; Bert Vogelstein; George J Netto
Journal:  Virchows Arch       Date:  2016-08-12       Impact factor: 4.064

Review 8.  [Multimodal therapy for bladder sparing with high grade bladder tumors].

Authors:  P J Goebell; W Legal; C Weiss; R Fietkau; B Wullich; S Krause
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

9.  Interobserver agreement of confocal laser endomicroscopy for bladder cancer.

Authors:  Timothy C Chang; Jen-Jane Liu; Shelly T Hsiao; Ying Pan; Kathleen E Mach; John T Leppert; Jesse K McKenney; Robert V Rouse; Joseph C Liao
Journal:  J Endourol       Date:  2013-02-14       Impact factor: 2.942

10.  Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.

Authors:  Farshid Dayyani; Bogdan A Czerniak; Kanishka Sircar; Mark F Munsell; Randall E Millikan; Colin P Dinney; Arlene O Siefker-Radtke
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.